Zoster vaccine safety surveillance

In the context of no safety signals identified during two years of surveillance in over 18,000 participants, AusVaxSafety concluded active surveillance of zoster vaccine safety in November 2018. It is important to re-emphasise that zoster vaccine should not be given to immunocompromised individuals. For more information please refer to the Therapeutic Goods Administration (TGA) website.

AusVaxSafety surveillance tools

svvt

Last updated May 2019